Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

DOP10: Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Shubhakar*1, B. Jansen1, A. Adams2, K. Reiding3, N. Ventham4, D. Bergemalm5, P. Urbanowicz1, R. Gardner1, IBD-BIOM Consortium1, J. Halfvarson6, J. Satsangi2, D. Fernandes1, M. Wuhrer7, D. Spencer1

1Ludger Ltd., Abingdon, UK, 2University of Oxford, Translational Gastroenterology Unit, Oxford, UK, 3Utrecht University, Division of Biomolecular Mass Spectrometry, Utrecht, The Netherlands, 4University of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, UK, 5Örebro University, Department of Gastroenterology, Örebro, Sweden, 6Örebro University, Örebro, Sweden, 7Leiden University Medical Center, Center for Proteomics and Metabolomics, Leiden, The Netherlands

DOP11: Lymphocyte activation gene (LAG)-3 on T cells is a potential therapeutic target in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Slevin*1, M. Tan1, C. Lahiff1, L. M. Wang2, B. Greenaway1, K. Lynch1, A. Geremia1, S. Hughes3, K. Leavens3, K. Nevin3, D. J. B. Marks3, R. Tarzi3, N. Srinivasan3, S. Travis1, C. Arancibia1, S. Keshav1

1University of Oxford, Translational Gastroenterology Unit, Oxford, UK, 2Changi General Hospital, SingHealth, Department of Laboratory Medicine, Singapore, Singapore, 3GlaxoSmithKline, Experimental Medicine Unit, Stevenage, UK

DOP12: Mutations in the X-linked inhibitor of apoptosis protein promote susceptibility to microbiota-induced intestinal inflammation

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Gopalakrishnan1,2, Y. Zeissig2, A. Strigli1, M. Basic3, J. Hartwig2, J. Wang4, M. Muders5, G. Barreton5, J. F. Baines4, A. Bleich3, J. Hampe1,5, S. Zeissig*1,2,5

1Center for Regenerative Therapies Dresden, TU Dresden, Dresden, Germany, 2University Hospital Schleswig-Holstein, Kiel, Germany, 3Hannover Medical School, Hannover, Germany, 4Max-Planck Institute for Evolutinary Biology, Kiel, Germany, 5University Hospital Carl-Gustav Carus, Dresden, Germany

DOP13: Immune profiling of adipose tissue in murine models of inflammatory bowel disease (IBD)

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Letizia*1, Y. Rodriguez Sillke1, F. Schmidt1, C. Günther2, D. Kunkel3, R. Glauben1, B. Siegmund1, C. Weidinger1

1Charité – Universitätsmedizin Berlin, Gastroenterologie, Infektiologie und Rheumatologie, Berlin, Germany, 2Universitätsklinikum Erlangen, Gastroenterologie, Erlangen, Germany, 3Charité – Universitätsmedizin Berlin, Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany

DOP14: TiO2 nanoparticles abrogate the protective effect of the autoimmunity-associated PTPN22R619W variant during acute DSS colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Schwarzfischer*1, L. Hering1, E. Katkeviciute1, A. Niechcial1, K. Atrott1, K. Bäbler1, P. Busenhart1, G. Rogler1, M. Scharl1, M. Spalinger1

1Department of Gastroenterology and Hepatology, University of Zürich, Zürich, Switzerland

DOP15: Metabolomics coupled with pathway analysis characterise metabolic changes in treatment-naive ulcerative colitis patients

ECCO '19 Copenhagen

Year: 2019
Authors:

J. Diab*1, T. Hansen1, R. Goll2, E. Jensen1, T. Moritz3, J. Florholmen4, G. Forsdahl1

1Natural Products and Medicinal Chemistry Research Group, Department of pharmacy, University of Tromsø The Arctic University of Norway, Tromsø, Norway, 2Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, University of Tromsø The Arctic University of Norway, Tromsø, Norway, 3Swedish Metabolomics Center, Swedish University of Agricultural Sciences, Umeå, Sweden, 4Research Group of Gastroenterology and Nutrition, Department of Clinical Medicine, Tromsø, Norway

DOP16: Endoplasmic reticulum stress in subepithelial myofibroblasts increases the TGF-β1 activity that regulates fibrosis in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Li*1, J. Kuemmerle1

1Virginia Commonwealth University, Internal Medicine, Richmond, USA

DOP17: AZD4205, a potent, GI tract-enriched, JAK1-selective inhibitor for treatment of inflammatory bowel disease (IBD)

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Wang*1, T. John2, L. Zhang1, L. Zhu1, Y. Xu1, K. Chen1, S. Han1, J. Li1, F. Wang1, C. Deceneux3,4, A. Behren3,4, Z. Yang1

1Dizal (Jiangsu) Pharmaceutical Co., Ltd., Shanghai, China, 2Austin Health, Heidelberg, Australia, 3Olivia Newton-John Cancer Research Institute, Heidelberg, Australia, 4La Trobe University, School of Cancer Medicine, Heidelberg, Australia

DOP18: OSM neutralisation in IBD mucosal explant cultures reduces pro-inflammatory cytokine production

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Vossenkamper1, K. Foster2, K. Nevin2, G. Tannahill*2, S. Flint2, T. T. McDonald1

1Blizard Institute, Barts and the London School of Medicine and Dentistry, Immunobiology, London, UK, 2GlaxoSmithKline, Immunoinflammation Unit, Stevenage, UK

DOP19: Spermidine treatment ameliorates experimental colitis in vivo

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Niechcial*1, E. Katkeviciute1, L. Hering1, M. Wawrzyniak1, M. Schwarzfischer1, K. Bäbler1, K. Attrot1, M. Scharl1,2, M. R. Spalinger1

1University Hospital Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 2University of Zurich, Zurich Center for Integrative Human Physiology, Zurich, Switzerland

DOP20: Drugs that modulate histone acetylation disrupt TGF-β-signalling and reduce collagen I expression in models of stricturing Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Lewis*1, A. Nijhuis1, G. Berti1, C. Felice2, R. Jeffrey1, S. Iqbal1, A. B. Pomeranc1, S. Aldelemi1, S. Mehta1, E. Giannoulatou3, R. Feakins4, A. Armuzzi2, J. O. Lindsay5, A. Silver1

1Blizard Institute, Barts and The London School of Medicine and Dentistry, Centre for Genomics and Child Health, London, UK, 2IBD Unit, Presidio Columbus, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy, 3Victor Chang Cardiac Research Institute and 4St Vincent’s Clinical School, University of New South Wales, Sydney, Australia, 4Department of Histopathology, The Royal London Hospital, London, UK, 5Blizard Institute, Barts and The London School of Medicine and Dentistry, Centre for Immunobiology, London, UK

DOP22: UC-related and segment-specific properties of patient-derived colonic organoids

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Suzuki*1, H. Shimizu1, M. Kawai1, J. Takahashi1, S. Anzai1, A. Kawamoto1, S. Nagata1, Y. Hiraguri1, S. Yui1, K. Tsuchiya1, T. Nakamura1, K. Ohtsuka1, K. Ohtsuka1, R. Okamoto1, M. Watanabe1

1Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan

DOP23: Myenteric plexitis and post-operative recurrence in Crohn’s disease: the role of enteric glial cells and ICAM-1

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Le Berre*1, J. Pabois1, T. Durand1, E. Durieu1, M. Rolli-Derkinderen1, C. Bossard2, J. Podevin3, M. Neunlist1, I. Neveu1, P. Naveilhan1, A. Bourreille1,4

1Nantes University Hospital, UMR Inserm 1235 – TENS, Gastroenterology department, Institut des Maladies de l’Appareil Digestif, Nantes, France, 2Nantes University Hospital, Pathology department, Nantes, France, 3Nantes University Hospital, Digestive surgery department, Institut des Maladies de l’Appareil Digestif, Nantes, France, 4Nantes University Hospital, CIC, INSERM 1413, Nantes, France

DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Weder*1, W. T. Van Haaften2, K. Baebler1, G. Rogler3, G. Dijkstra4, P. H. Imenez Silva5, Y. Wang5, C. De Vallière3, C. Wagner5, I. Frey-Wagner3, K. Seuwen6, P. Ruiz3, M. Hausmann3

1University of Zurich, Zurich, Switzerland, 2University Medical Center Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands, 3University Hospital Zurich, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 4University of Groningen, Department of Gastroenterology and Hepatology, Groningen, The Netherlands, 5University of Zurich, Institute of Physiology, Zurich, Switzerland, 6Novartis Institutes for Biomedical Research, Basel, Switzerland

DOP25: Unravelling vedolizumab mechanism of action in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Veny*1, A. Garrido1, H. Bassolas-Molina1, M. C. Masamunt1, M. Esteller1, M. Arroyes1, A. M. Corraliza1, E. Tristán2, A. Fernández-Clotet1, I. Ordás1, E. Ricart1, M. Esteve2, J. Panés1, A. Salas1

1IDIBAPS, Hospital Clínic, CIBERehd, Department of Gastroenterology, Barcelona, Spain, 2Hospital Universitari Mutua Terrassa, Department of Gastroenterology, Terrassa, Spain

DOP26: Biological therapy increases NCR+ ILC3 levels in IBD patients

ECCO '19 Copenhagen

Year: 2019
Authors:

B. Creyns*1,2, B. Verstockt2,3, J. Cremer1,2, V. Ballet3, M. Ferrante2,3, S. Vermeire2,3, J. Ceuppens1, G. Van Assche2,3, C. Breynaert1

1KU Leuven, Department of Microbiology and Immunology, Leuven, Belgium, 2KU Leuven, Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID), Leuven, Belgium, 3University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium

DOP27: Sequencing-based hematopoietic miRNA landscape reveals common and distinct features of autoimmune inflammatory phenotypesECCO '19 Copenhagen
Year: 2019
Authors:

S. Juzenas*1,2, M. Hübenthal1, S. Zeißig3, N. Strüning4, A. Keller5, D. Schulte6, M. D’Amato7,8, M. Lindqvist9, J. Kupčinskas2,11, S. Schreiber1,12, J. Halfvarson13, G. Hemmrich-Stanisak1, A. Franke1

1Christian-Albrechts-University of Kiel, Institute of Clinical Molecular Biology, Kiel, Germany, 2Institute for Digestive Research, Lithuanian University of Health Sciences, Kaunas, Lithuania, 3Department of Medicine, TU Dresden, Dresden, Germany, 4Department of Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany, 5Chair for Clinical Bioinformatics, Saarland University, Saarbrücken, Germany, 6Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel, Germany, 7Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden, 8Basque Foundation for Science, BioCruces Health Research Institute and IKERBASQUE, Bilbao, Spain, 9Department of Medical Sciences, Örebro University, Örebro, Sweden, 11Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania, 12Department of Internal Medicine, University Hospital Schleswig-Holstein, KIel, Germany, 13Department of Gastroenterology, Örebro University, Örebro, Sweden

DOP28: Maternal obstetric outcomes in women with IBD compared with the general population

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Lever1, T. Glanville1, C. Selinger*2

1Leeds Teaching Hospitals NHS Trust, Leeds, UK, 2Leeds Teaching Hospitals NHS Trust, Gastroenterology, Leeds, UK

DOP29: Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Moens*1,2, C. van der Woude3, M. Julsgaard4, S. Sebastian5,6, N. Arebi7, M. Alzinaty7, E. Humblet8, K. B. Kok9, J. Sheridan10, C. Gilletta De Saint-Joseph11, S. Nancey12, J-F. Rahier13, P. Bossuyt14, A. Cremer15, S. Dewit16, C. Eriksson17, F. Hoentjen18, T. Krause19, E. Louis20, E. Macken21, Z. Milenkovic22, J. Nijs23, A. Posen24, A. Van Hootegem25, W. Van Moerkercke26, S. Vermeire1,2, A. Bar-Gil Shitrit27, M. Ferrante1,2

1University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 2Catholic University Leuven, Chronic Diseases, Metabolism and Ageing, Leuven, Belgium, 3Erasmus MC, Department of Gastroenterology and Hepatology, Rotterdam, The Netherlands, 4Aarhus University Hospital, Department of Gastroenterology and Hepatology, Aarhus, Denmark, 5Hull and East Yorkshire NHS Trust, IBD Unit, Hull, UK, 6University of Hull and York, Hull York Medical School, Hull, UK, 7St. Marks Hospital, Department of Gastroenterology, London, UK, 8Ziekenhuis Oost-Limburg – Campus Sint-Jan, Department of Gastroenterology, Genk, Belgium, 9Barts Health NHS Trust, Department of Gastroenterology, London, UK, 10St. Vincent’s University Hospital, Department of Gastroenterology, Dublin, Ireland, 11Hôpital Rangueil, Department of Gastroenterology, Toulouse, France, 12CHU Lyon, Department of Gastroenterology and Hepatology, Lyon, France, 13CHU UCL Namur, Université catholique de Louvain, Deparment of Gastroenterology, Yvoir, Belgium, 14Imeldaziekenhuis, Department of Gastroenterology, Bonheiden, Belgium, 15Hôpital Erasme, Université Libre de Bruxelles, Department of Gastroenterology, Brussels, Belgium, 16Mariaziekenhuis Noord-Limburg, Department of Gastroenterology, Overpelt, Belgium, 17Faculty of Medicine and Health Orebro University, Department of Gastroenterology, Orebro, Sweden, 18Radboud UMC, Department of Gastroenterology, Nijmegen, The Netherlands, 19Opernstrasse, Department of Gastroenterology, Kassel, Germany, 20CHU Liège, Department of Gastroenterology, Liège, Belgium, 21Universiteit ziekenhuis Antwerpen, Department of Gastroenterology, Antwerpen, Belgium, 22Military Medical Academy Belgrade, Department of Gastroenterology, Belgrade, Serbia, 23Sint-Trudo Ziekenhuis, Department of Gastroenterology, St-Truiden, Belgium, 24AZ Vesalius, Department of Gastroenterology, Tongeren, Belgium, 25AZ Klina, Department of Gastroenterology, Brasschaat, Belgium, 26AZ Groeninge, Department of Gastroenterology, Kortrijk, Belgium, 27Shaare Zedek Medical Center, Hebrew University Jerusalem, Digestive diseases institute, Jerusalem, Israel

DOP30: Factors associated with life satisfaction in people with Crohn’s disease and ulcerative colitis: results from the national 2018 Crohn’s and Colitis UK Inflammatory Bowel Disease Quality of Life Survey

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Rowse*1, S. Hollobone2, S. Afhim2, P. Oliver3

1University of Sheffield, Clinical Psychology Unit, Sheffield, UK, 2Crohn’s and Colitis UK, St Albans, UK, 3University of Sheffield, Academic Unit of Primary Medical Care, Sheffield, UK